Using high-resolution PET-CT imaging during lung surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study investigates the use of a high-resolution PET-CT imaging system during thoracic surgery to evaluate resection margins and lymph node status in real-time. The imaging allows for quick assessments, estimated to take under 10 minutes per specimen, enabling surgeons to make informed decisions on surgical steps as they proceed. The goal is to enhance surgical outcomes by providing immediate feedback on the effectiveness of tumor removal.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient is 18 years of age or older.
* Patient with suspected or confirmed lung malignancies
* Patient is indicated to undergo thoracic surgery.
* Patient is estimated to be compliant for study participation by the investigator.
* Patient has freely given his/her informed consent to participate in this study.

Exclusion Criteria:

* Patient has general or local contra-indications for thoracic surgery.
* Patient has active infection.
* Blood glucose level over 200 mg/dL on the day of surgery.
* Pregnancy or lactation.
* Patient participated in other clinical studies with radiation exposure of more than 1 mSv in the past year

Where it's running

• University Hospital Ghent
  Ghent, Belgium Recruiting

Study contacts

• Study coordinator: Liesbeth Desender, prof. dr.
• Email: liesbeth.desender@uzgent.be
• Phone: +32 9 332 63 88

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-assisted longitudinal CT to guide indeterminate lung nodules

  This trial tests whether giving doctors an AI report that tracks nodules over serial CT scans helps reduce unnecessary benign lung resections in patients with indeterminate nodules.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07895277

• MRD-guided postoperative monitoring and adaptive treatment for resectable NSCLC

  This study tests a personalized follow-up and treatment plan using ctDNA MRD testing and pathology to guide adjuvant therapy after surgery for stage IB-IIIA NSCLC treated with neoadjuvant immunotherapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07894458

• Telerehabilitation exercise program after lung cancer surgery

  A remote rehabilitation program with guided exercises is tested to help adults after lung cancer surgery recover better.

  Recruiting University of Seville · Seville, Andalusia · NCT07861282

• Impact of Exercise on Tumor Immunity in NSCLC Patients Receiving Neoadjuvant Chemo-Immunotherapy

  A structured exercise program is being tested to see if it boosts immune cells in the tumor for patients with resectable NSCLC undergoing pre-surgery chemo-immunotherapy.

  Recruiting at 2 sites Centre Leon Berard · Lyon, Rhône and 1 other locations · NCT07786909

• Low-Dose CT Lung Cancer Screening in Kuwait: Feasibility and Uptake

  This pilot tests whether offering low-dose CT lung cancer screening to high-risk adults in Kuwait is workable and acceptable, with about 500 participants completing a baseline scan.

  Recruiting Chest Diseases Hospital, Ministry of Health, Kuwait · Kuwait City · NCT07766538

• Nitride-based Raman biochip for lung cancer diagnosis and monitoring

  A large observational study in Taiwan will test whether a blood-based nitride-based Raman biochip can help diagnose lung cancer and monitor patients over time.

  Recruiting Taichung Veterans General Hospital · Taichung · NCT07755020

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.